Trials / Completed
CompletedNCT03426644
Mobile Health Sleep and Growth Study 2
Normative Feedback and Framing Incentives to Encourage Sleep Extension in Children
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Children's Hospital of Philadelphia · Academic / Other
- Sex
- All
- Age
- 10 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
Investigators seek to determine if an online behavioral economic based intervention can be developed to target increases in childhood time in bed (TIB).
Detailed description
Investigators seek to determine if an online behavioral economic based intervention can be developed to target increases in childhood time in bed (TIB). The primary objectives of this study are to determine if the behavioral economic strategy of compensatory effect leads to the middle time in bed (TIB) target to be most commonly selected, and if the behavioral economic strategies of normative feedback and loss-framed incentives lead to longer TIB and therefore longer total sleep time.Children aged 10-12 who sleep about 7-8 hours per night will wear a FitBit for 11 weeks in order to measure time in bed and total sleep time. Participants will have a time in bed goal to meet each night. Participants will be randomized to one of four study arms and receive text and/or email messaging from the study about sleep hygiene. Some study arms receive additional messaging. The study involves two visits to the Children's Hospital of Philadelphia (CHOP) Roberts Center for Pediatric Research.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mobile Sleep and Growth Study | The intervention is designed to test if sleep tips delivered by text messages can aid with reaching time in bed targets. And if additional motivational text messages can further aide with reaching time in bed targets. |
Timeline
- Start date
- 2018-02-26
- Primary completion
- 2018-12-17
- Completion
- 2018-12-17
- First posted
- 2018-02-08
- Last updated
- 2023-01-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03426644. Inclusion in this directory is not an endorsement.